Laboratory Tests
This section focuses on FDA-approved diagnostic HIV tests for use in moderate and high complexity laboratories.
Laboratory Testing Guidance
- Revised and updated 2017 APHL Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm
- Full Version of the Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations
- Technical Update on HIV-1/2 Differentiation Assays, August 2016
- Updated October 2017 Technical Update: Use of the Determine HIV 1/2 Ag/Ab Combo Test with Serum or Plasma in the Laboratory Algorithm for HIV Diagnosis
FDA Approved HIV Tests
- Updated September 2017 Advantages and Disadvantages of Different Types of HIV tests
- Updated December 2016 Laboratory Screening Tests
- Updated November 2016 Supplemental Tests for Laboratory Settings
- Updated November 2016 Moderate Complexity Rapid HIV Tests for Clinical Settings
- Updated May 2016 Alere Determine™ HIV-1/2 Ag/Ab Combo Information Sheet for Testing Programs
- Updated November 2016 CLIA-waived rapid HIV tests
Resources
- New Item 2017 Highlights from the 2016 HIV diagnostics conference: The new landscape of HIV testing in laboratories, public health programs and clinical practice
- New item 2017 New HIV Testing Technologies: Implications for your Laboratory
- Association of Public Health Laboratories (APHL) HIV Testing Resources (includes recent manufacturer news)
- Detection of Acute HIV Infection in Two Evaluations of a New HIV Diagnostic Testing Algorithm — United States, 2011–2013
-
2013 Journal of Clinical Virology Supplement: HIV Laboratory Diagnosis: New Tests and a New Algorithm.
(Select year 2013 then Vol. 58 December, 2013 p.e1-e134-Supplement 1) - HIV Diagnostic Conference
- Page last reviewed: September 21, 2017
- Page last updated: October 6, 2017
- Content source: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention